NFKB1 and psoriasis: In the present study, the results indicated that the NF-κB and MAPKs signaling pathways were inhibited by cimifugin in psoriasis-like models, which further demonstrated that the protective effects of cimifugin in psoriasis-like pathogenesis were associated with the inactivation of NF-κB/MAPK.